Lemaitre Vascular Inc (LMAT)

R&D Expense Growth

19.38%

Quarterly · Period ending:

LMAT logo

LMAT R&D Expense Growth

Latest reported19.38%
LMAT Quarterly R&D Growth (QoQ) (0.00% → 19.38%)
High-resolution chart · PNG

LMAT r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lemaitre Vascular Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
19.3842%
14.9165%
18.9562%
-16.1254%
-13.5287%
13.1841%
-1.0394%
-14.6592%
4.6921%
-5.9527%
3.0066%
-6.4659%
16.5419%
9.0321%
2.6574%
3.4668%
14.1201%
-15.1866%
21.3834%
7.3906%
-6.7511%
-0.8714%
36.7493%
-1.9168%
-28.5571%
19.8079%
9.5572%
1.1082%
0.7143%
-4.559%
15.2185%
2.4648%
8.9315%
15.2874%
-10.1079%
7.7723%
-1.4475%
9.0072%
-1.1696%
-5.814%
13.0014%
-8.1905%
10.8374%
6.7618%
15.5382%
6.568%
-2.5248%
-2.4626%
-15.4018%
-4.1369%
7.8462%
2.5237%
-0.3928%
-18.4497%
23.7906%
11.1013%
0%
-0.3512%
16.9405%
-6.3462%
-18.239%
-13.7627%
29.9559%
-15.1719%
-13.1169%
-10.2564%
18.5083%
0.9059%
9.4584%
0.7686%
8.1463%
-18.3853%
9.1852%
14.8936%
2.7098%
2.3256%
-3.1196%
61.3986%
-11.1801%
-18.357%
24.0252%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.